hoodb.com

Zion Pharma宣佈與Roche達成協議,就血腦屏障滲透性口服HER2酪氨酸激酶抑制劑進行開發和商業化

|

You are leaving and open the following URL" of about "zn" news

news.google.com/rss/articles/CBMibEFVX3lxTE5kNDBkZnF6V3NqTHFmRVF2MWUyYzZNa2tvUWh1RzJtZTdwUWtYaUdGN3hRVXU4Y051d09OLUczUFZCaFRqazJxSHlGQkVXYXVqYWlfdDRaUmJPaVBWRnRyQ2REYWR2OTIwVnY2Yg?oc=5


Continue Opne >

zn: Zion Pharma宣佈與Roche達成協議,就血腦屏障滲透性口服HER2酪氨酸激酶抑制劑進行開發和商業化


More zn news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/SE/zn.xml in /var/www/hoodb/function.php on line 339
1734915813-
Warning: file_put_contents(aCache/aaa/gnews/SE//zn.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About zn

from
1734915814-1734462290

Warning: filemtime(): stat failed for aCache/search/se/zn in /var/www/hoodb/function.php on line 339
1734915814-

zn, Zion Pharma宣佈與Roche達成協議,就血腦屏障滲透性口服HER2酪氨酸激酶抑制劑進行開發和商業化 2022 zn

Zion Pharma宣佈與Roche達成協議,就血腦屏障滲透性口服HER2酪氨酸激酶抑制劑進行開發和商業化

Choose Your Country or Region


Back to Top



Zion Pharma宣佈與Roche達成協議,就血腦屏障滲透性口服HER2酪氨酸激酶抑制劑進行開發和商業化

Copyright © 2020-2021 hoodb.com. All Rights Reserved.